Mirati Therapeutics, Inc. (MRTX) Analyst Forecast

NASDAQ Currency in USD Disclaimer

$58.70

north_east NA Past Year
Day's range
$58.54
Day's range
$58.99

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
12/13/2022 Piper Sandler Swapnil Malekar $68.00 $41.97   62.02%
12/07/2022 BMO Capital Evan Seigerman $59.00 $49.59   18.98%
12/07/2022 Piper Sandler Swapnil Malekar $84.00 $49.59   69.39%
01/31/2022 Bank of America Securities Jason Gerberry $141.00 $123.02   14.62%
09/20/2021 H.C. Wainwright Edward White $247.00 $167.09   47.82%
09/19/2021 Jefferies Maury Raycroft $193.00 $177.45   8.76%

Mirati Therapeutics, Inc. FAQ's

What analysts cover Mirati Therapeutics, Inc.?

Mirati Therapeutics, Inc. has been rated by research analysts at Morgan Stanley, Leerink Partners, Piper Sandler, Citigroup, Oppenheimer, J.P. Morgan in the past 90 days.